Elanco Animal Health Inc [NYSE: ELAN] traded at a high on 2025-07-02, posting a 2.01 gain after which it closed the day’ session at $6320000.0.
The results of the trading session contributed to over 4666789 shares changing hands. Over the past one week, the price volatility of Elanco Animal Health Inc stands at 2.86% while the volatility over the past one month is 2.90%.
The market cap for ELAN stock reached $7.31 billion, with 496.46 million shares outstanding and 491.95 million shares in the current float. Compared to the average trading volume of 6.32M shares, ELAN reached a trading volume of 4666789 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Elanco Animal Health Inc [ELAN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELAN shares is $14.91 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELAN stock is a recommendation set at 1.64. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for Elanco Animal Health Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 26, 2025. While these analysts kept the previous recommendation, UBS raised their target price to Buy. The new note on the price target was released on December 09, 2024, representing the official price target for Elanco Animal Health Inc stock. Previously, the target price had yet another raise to $14, while Leerink Partners analysts kept a Market Perform rating on ELAN stock. On September 19, 2024, analysts decreased their price target for ELAN shares from 17 to 15.
The Price to Book ratio for the last quarter was 1.15, with the Price to Cash per share for the same quarter was set at 0.98. Price to Free Cash Flow for ELAN in the course of the last twelve months was 21.07 with Quick ratio for the last quarter at 1.46.
How has ELAN stock performed recently?
Elanco Animal Health Inc [ELAN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.98. With this latest performance, ELAN shares gained by 9.69% in over the last four-week period, additionally plugging by 22.06% over the last 6 months – not to mention a rise of 21.55% in the past year of trading.
Elanco Animal Health Inc [ELAN]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Elanco Animal Health Inc [ELAN] shares currently have an operating margin of 5.40% and a Gross Margin at 43.10%. Elanco Animal Health Inc’s Net Margin is presently recorded at 8.43%.
Return on Equity for this stock inclined to 2.77%, with Return on Assets sitting at 2.77%.
Earnings analysis for Elanco Animal Health Inc [ELAN]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELAN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elanco Animal Health Inc go to 6.11%.
Insider trade positions for Elanco Animal Health Inc [ELAN]
There are presently around $101.48%, or 102.54%% of ELAN stock, in the hands of institutional investors. The top three institutional holders of ELAN stocks are: DODGE & COX with ownership of 83.58 million shares, which is approximately 16.9128%. PRIMECAP MANAGEMENT CO/CA/, holding 52.8 million shares of the stock with an approximate value of $$761.94 million in ELAN stocks shares; and PRIMECAP MANAGEMENT CO/CA/, currently with $$713.53 million in ELAN stock with ownership which is approximately 10.0056%.
